Oncology Analytics

The company's primary clients are health plans, for whom it provides benefits management and analytical solutions. Oncology Analytics generates revenue by offering these technology-enabled services to insurance companies, helping them manage the total cost of cancer care. Its business model is centered on collaborating with health plans to ensure that their members receive appropriate and cost-effective anti-cancer therapies based on scientific evidence and patient-specific data. By 2018, the company supported over 3.5 million health plan members across the U.S., with major clients including Humana and HealthPartners.

The core of the company's offering is its e-Prior Authorization platform, OneUMTM. This cloud-based software is used by oncologists to manage prior authorization requests for a full spectrum of cancer treatments, including chemotherapy, radiation, precision medicine, and supportive care. The platform integrates clinical data from various sources like EMRs, lab reports, and biomarker data, combining it with claims data to provide deep insights into oncology drug spending and provider performance. A key differentiator is the firm's reliance on board-certified oncologists and pharmacists for peer-to-peer consultations, rather than using only nurses or automated technology, to review complex cases and ensure nuanced, collaborative decision-making.

Significant milestones include a $21 million Series B funding round in November 2018, led by Oak HC/FT, which was intended to expand its benefits management capabilities and data science investments. This financing followed a move of its headquarters from Plantation, Florida, to Atlanta to access a larger talent pool. The 2021 rebranding to OncoHealth signaled the company's evolution and its expanding portfolio of digital health solutions, including real-world evidence and virtual care services, developed in a period of significant growth.